Fundraising Fox
Avenue Biosciences
Helsinki, FI · Founded 2023 · 23 employees on LinkedIn · 7 known investors
Find your way into Avenue Biosciences
Sign up to find every way you can get introduced to Avenue Biosciences
- Your email: who you already know at Avenue Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Avenue Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Avenue Biosciences develops machine learning-enabled chemistry and software to accelerate the discovery and manufacturing of protein biologics for the biotechnology and therapeutics industry. The company combines high-throughput chemistry with computational tools to overcome production barriers in protein drug development.
Founders & leadership
Avenue Biosciences was founded in 2023 by Ville Paavilainen.
Investors · 7
How we know: funding news · tech.eu · Not right? Tell us
How we know: Inventure's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · funding news · tech.eu · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$11.4M disclosed across 2 rounds · 2026
- $5.7MSeed ExtensionJan 2026 · 2 sources
Balnord (lead), Tesi (lead), Dimerent, Inventure, University of Helsinki, Voima Ventures
Source ↗ - $5.7MraisedJan 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Avenue Biosciences do?
- Avenue Biosciences develops machine learning-enabled chemistry and software to accelerate the discovery and manufacturing of protein biologics for the biotechnology and therapeutics industry. The company combines high-throughput chemistry with computational tools to overcome production barriers in protein drug development.
- Who founded Avenue Biosciences?
- Avenue Biosciences was founded by Ville Paavilainen in 2023.
- Who are Avenue Biosciences's investors?
- Avenue Biosciences's investors include Balnord Sp. z o.o., Inventure, Inventure, Voima Ventures.
- How much funding has Avenue Biosciences raised?
- Avenue Biosciences has disclosed $11.4M raised across 2 rounds.
- Where is Avenue Biosciences headquartered?
- Avenue Biosciences is headquartered in Helsinki, FI.